Translate this page into:
Immunohistochemical detection of axillary lymph node micrometastases in node negative breast cancer patients using cytokeratin and epithelial membrane antigen
*Corresponding author: Dr. Mukta Pujani. drmuktapujani@gmail.com
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
Background and Objective: The study was conducted to detect occult metastases in lymph node negative breast cancer patients using cytokeratin (CK) and epithelial membrane antigen (EMA) immunohistochemistry (IHC) and correlate this with primary tumor size and grade. Materials and Methods: A total of 32 cases including 12 prospective and 20 retrospective cases of axillary lymph node negative breast cancer were studied. CK and EMA IHC were performed to detect micrometastases. Results: Axillary lymph node metastases were detected in 18.75% of previously node negative cases using CK and EMA IHC. CK was found to be more sensitive for detection of metastases compared to EMA. A highly significant correlation was observed between tumor grade and axillary lymph node metastases detected by CK and EMA. However, no significant correlation was found between tumor size and axillary lymph node metastases detected by IHC. Conclusion: In the present study, there was an increase of 18.75% in the occult metastases detection rate using CK and EMA. To conclude, IHC detection of occult metastases should be done using CK in all axillary node negative cases, especially in T1 and T2 stage tumors.
Keywords
References
- Park K. Epidemiology of chronic non-communicable diseases and conditions. In: Park′s Textbook of Preventive and Social Medicine. 18 th ed. Jabalpur: Banarasidas Bhanot; 2005. p. 303.
- Saunders CM, Baun M. The breast. In: Russell RC, Bulstrode CJ, editors. Bailey and Love′s Short Practice of Surgery. 23 rd ed. London: Arnold; 2000. p. 749-72.
- Chua B, Olivotto IA, Donald JC, Hayashi AH, Doris PJ, Turner L, et al. Outcomes of sentinel lymph node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg 2003;185:182-26.
- AJCC (American Joint Committee on Cancer) Cancer Staging Manual. In: Edge SB, Byrd DR, Compton CC, et al. editors. 7 th ed. New York: Springer-Verlag; 2010. p. 347-77.
- Kohlberger P, Gantert M, Volk-Orlowska T, Kieback DG, Gitsch G. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients. Anticancer Res 2001;21:697-9.
- Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY. The immunohistochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193-7.
- Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, et al. Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 2005;23:1379-89.
- Viale G, Zurrida S, Maiorana E, Mazzarol G, Pruneri G, Paganelli G, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma in a single institution. Cancer 2005;103:492-500.
- Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896-900.
- Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993;80:459-63.
- Wong SL, Chao C, Michael EJ, Simpson D, McMasters KM. University of Louisville Breast Cancer Study Group. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:330-4.
- Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of the clinical nodal staging and of limited axillary dissection as a determinant of hiostologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
- Critical assessment of the clinical TNM system in breast cancer. Report from the Yorkshire Breast Cancer Group. Br Med J 1980;281:134-6.
- Tavassoli FA. General considerations. In: Tavassoli FA, editor. Pathology of the Breast. 1992. p. 25-62.
- Sakaguchi M, Virmani A, Dudak MW, Peters GN, Leitch AM, Saboorian H, et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol 2003;10:117-25.
- Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 2009;115:1555-62.
- Safai A, Razeghi A, Monabati A, Azarpira N, Talei A. Comparing touch imprint cytology, frozen section analysis, and cytokeratin immunostaining for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Indian J Pathol Microbiol 2012;55:183-6.
- Vincent-Salomon A, Bidard FC, Pierga JY. Bone marrow micrometastasis in breast cancer: Review of detection methods, prognostic impact and biological issues. J Clin Pathol 2008;61:570-6.